Navigation Links
Cell Biosciences Announces Publication in Nature Medicine
Date:4/13/2009

PALO ALTO, Calif., April 13 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the publication of a landmark study by a research team from Stanford University School of Medicine. Dr. Dean W. Felsher, Associate Professor of Oncology, was senior author on the study. The publication, titled "Nano-fluidic proteomic assay for serial analysis of oncoprotein activation in clinical samples", appeared on April 12, 2009 as an Advance Online Publication in the prestigious journal Nature Medicine. In this work, the authors report on new methods for detecting small modifications in cancer-related proteins. Importantly, the exceptional sensitivity of the methods enabled oncoprotein studies in extremely small tumor samples derived from cancer patients. This work was performed using a protein analysis system from Cell Biosciences.

"Current protein research methods have difficulty detecting subtle changes in oncoprotein activation, changes that underlie critical cancer signaling processes," explained lead author Dr. Alice Fan. "To develop new therapeutics for cancer, we need better tools for understanding the intricate control mechanisms within cancer cells. This novel nanofluidic technology is incredibly exciting because it enables us to measure cancer proteins that could not be feasibly measured before in limited patient samples.

Due to its unique nanofluidic design, the Cell Biosciences system uses exceptionally small test samples - the authors report using only 4 nanoliters per test. "The extremely high detection sensitivity of our system is enabling a whole host of new experimental methods for cancer researchers," said Tim Harkness, President and CEO of Cell Biosciences. "It is gratifying to see the adoption of our technology by cutting-edge researchers like the Stanford team."

The Cell Biosciences protein analysis system is an ultrasensitive nanofluidic immunoassay system designed to analyze extremely small biological samples. Traditional protein analysis techniques can require as many as 100,000 cells, which complicates protein analysis in limited samples. The Cell Biosciences system can measure cell signaling proteins reproducibly in as few as 25 cells.

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nanoproteomics. We develop instrumentation systems, software, and assay products that reveal previously undetectable information about cellular control pathways. Our customers include leading institutions in the fields of cancer research, stem cell biology, and diabetes. Our products enable researchers to uncover fundamental mechanisms controlling cell proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Biosciences is located in Palo Alto, California. For more information, visit www.cellbiosciences.com.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cell Biosciences Closes $10 Million Series C Financing
2. SAFC Biosciences(R) Expands Media Capability for Chinese Hamster Ovary (CHO) Cell Lines
3. SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free
4. Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
5. Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
6. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
7. Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
8. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
9. Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners Spring 2009 Micro/Small-Cap Investor Conference
10. Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds
11. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... Research and Markets has announced ... report to their offering. ... The study ... delivery plasmids, chassis organisms, synthetic cells, production systems), enabling ... bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, ...
(Date:2/16/2017)... Feb. 16, 2017 UCHealth ( Aurora, ... LungDirect for pulmonary nodule patient management. In addition to ... a spot on the lung, UCHealth looks to improve ... data entry. Stephanie Brown, RN , ... nodule patients with an Excel spreadsheet, which was extremely ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:2/6/2017)... , Feb. 6, 2017 According ... security are driving border authorities to continue to ... reports there are 2143 Automated Border Control (ABC) ... currently deployed at more than 163 ports of ... 2013 to 2016 achieving a combined CAGR of ...
Breaking Biology News(10 mins):